DUBLIN, Calif., Feb. 21 /PRNewswire-FirstCall/ -- SuperGen, Inc. today announced that the company will issue its fourth quarter and year end 2005 financial results on Thursday, February 23, 2006 at 4:00 p.m. EST. SuperGen will host a conference call with the financial community to discuss operational and financial results for the three and twelve months ended December 31, 2005 and any revised outlook for the future. A live webcast of this conference call will begin at 4:30 p.m. EST on Thursday, February 23, 2006.
This call is being webcast by CCBN and can be accessed in the Investor Relations section of SuperGen’s web site at http://www.supergen.com. A replay will be available in the same location for 90 days following the call.
The webcast is also being distributed over CCBN’s Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN’s individual investor center at http://www.fulldisclosure.com or by visiting any of the investor sites in CCBN’s Individual Investor Network. Institutional investors can access the call via CCBN’s password-protected event management site, StreetEvents (http://www.streetevents.com).
About SuperGen
Based in Dublin, California, SuperGen is a pharmaceutical company dedicated to the acquisition, rapid development and commercialization of therapies for solid tumors, hematological malignancies and blood disorders. SuperGen’s product portfolio includes: Nipent(R) (pentostatin for injection); Mitomycin (generic brand of Mutamycin(R)); and SurfaceSafe(R) cleaner.
For more information about SuperGen, please visit http://www.supergen.com. Contacts: Timothy L. Enns Sharon Weinstein SuperGen, Inc. Noonan Russo Tel: (925) 560-0100 x111 Tel: (212) 845-4271 E-mail: tenns@supergen.com E-mail: sharon.weinstein@eurorscg.com
SuperGen, Inc.
CONTACT: Timothy L. Enns of SuperGen, Inc., Tel: +1-925-560-0100 x111,E-mail: tenns@supergen.com; or Sharon Weinstein of Noonan Russo, Tel:+1-212-845-4271, E-mail: sharon.weinstein@eurorscg.com, for SuperGen, Inc.
Web site: http://www.supergen.com/
